Ecothiopate iodide


Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2020 on request of the Sponsor.

On 24 April 2015, orphan designation (EU/3/15/1474) was granted by the European Commission to JJGConsultancy Ltd, United Kingdom, for ecothiopate iodide for the treatment of Stargardt's disease.

Key facts

Active substance
Ecothiopate iodide
Intented use
Treatment of Stargardt's disease
Date of designation
Orphan designation status
EU designation number

Review of designation

The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.

Sponsor's contact details

JJGConsultancy Ltd
Sherston House
High Street
Somerset BA4 6HZ
United Kingdom
Tel. +44 (0)1749 838886
Fax +44 (0)1749 838887

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating